Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by sjsearcheron Jun 17, 2018 5:52pm
121 Views
Post# 28183685

RE:USA Cannabis

RE:USA Cannabis As a U.S. investor, I trade LDSYF on the U.S. OTC, not LDS on the TSX exchange.

Because this is a Canadian stock, average daily volume for LDS is 390,900 shares. LDSYF on the other hand, only trades an average daily volume of 132,784.

U.S. investors need LDSYF to get more publicity and marketing, so more people know about it, and thereby buy shares. Hopefully, when substantial revenue starts coming in, U.S. investors will take notice. If/when average daily trading volume increases substantially, it will be much more difficult for stock manipulators and shorts to control the s.p.

I look forward to the day when LDSYF trades on the Nasdaq, instead of the OTC pink sheets, but that's going to take a while I'm afraid. Meanwhile, as investors, anything.we can do to spread the positive word about LDS/LDSYF will help all longs.
Bullboard Posts